FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Sonar Software App Cleared for Respiration Measure

FDA clears a Sound Life Sciences 510(k) for its sonar software for consumer smart devices for measuring breathing.

Federal Register

FDA Withdraws 5 No-Longer Marketed ANDAs

Federal Register notice: FDA withdraws approval of five ANDAs from multiple applicants because they are no longer marketed.

Human Drugs

Merck sBLA for Pneumococcal Vaccine

FDA accepts for review a Merck supplemental BLA for Vaxneuvance (pneumococcal 15-valent conjugate vaccine) for preventing invasive pneumococcal diseas...

Human Drugs

Complete Response Letter for Plinabulin

FDA tells BeyondSpring Pharmaceuticals a second study is needed to demonstrate substantial benefit of its plinabulin in preventing chemotherapy-induce...

Federal Register

Class 2 for Isocapnic Ventilation Devices

Federal Register notice: FDA classifies isocapnic ventilation devices into Class 2 (special controls), following a de novo classification request from...

Federal Register

Info Collection on Investigator Financial Disclosures

Federal Register notice: FDA seeks comments on an information collection extension entitled Financial Disclosure by Clinical Investigators.

Federal Register

FDA Patient Engagement Panel Renewal

Federal Register notice: FDA renews its Patient Engagement Advisory Committee for an additional two years beyond the charter expiration date.

Human Drugs

FDA Approves Darzalex Faspro for Myeloma

FDA approves Janssens Darzalex Faspro plus Kyprolis and dexamethasone to treat some multiple myelomas.

Human Drugs

GDUFA Science and Research Priority Initiatives

FDA publishes 15 GDUFA scientific and research priorities for FY 2022.

Human Drugs

CTI BioPharma Myelofibrosis NDA Review Extended

FDA extends by three months its review of a CTI BioPharma NDA for treating adult patients with intermediate or high-risk primary or secondary myelofib...